🇺🇸 FDA
Patent

US 11419318

Genetically modified rat comprising a humanized TRKB locus

granted A61KA61K49/0008

Quick answer

US patent 11419318 (Genetically modified rat comprising a humanized TRKB locus) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K49/0008